Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a video-based therapy transform hospital stays for autistic teens?

NCT ID NCT07701915

Disease control Sponsor: Caring Technologies, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a telehealth-delivered applied behavior analysis (ABA) program can improve care for autistic adolescents and young adults hospitalized due to severe challenging behaviors like aggression or self-injury. Participants are randomly assigned to receive either standard hospital care alone or standard care plus the TeleABA program, which includes behavior assessments, staff coaching, caregiver training, and post-discharge support. Researchers will compare changes in irritability, caregiver stress, and hospital experience to see if the program leads to better outcomes and a smoother transition home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a telehealth-delivered applied behavior analysis (ABA) program called TeleABA
What this could lead to
If it works, this could provide a scalable way to reduce severe behavioral crises in autistic youth and make hospital stays less stressful for families.
What could go wrong
This is a relatively small trial testing a behavioral intervention, so results may not apply broadly. The program depends on hospital staff and caregiver engagement, which can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12 years or older. * Established or documented diagnosis of autism spectrum disorder (ASD) in the electronic medical record or confirmed by the attending provider using DSM-5 criteria. * Admitted to a participating Hackensack Meridian Health hospital due to behavioral concerns (e.g., aggression, self-injury, elopement, or property destruction) that contribute to or prolong hospitalization. * Behavioral support identified by the attending provider as a primary component of the current admission. * Caregiver or legally authorized representative (LAR) able to provide informed consent. * Patient assent obtained when applicable. * Voluntary, court-mandated, and ward-of-the-state admissions are eligible. Exclusion Criteria: * Admission for an acute medical condition in which behavioral concerns are not a primary driver of hospitalization. * Medical instability that precludes participation in telehealth sessions. * Absence of a caregiver or legally authorized representative able to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder (ASD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder (ASD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services (CSH-RUCARES)

    Somerset, New Jersey, 08873, United States

  • Hackensack Meridian Health Jersey Shore University Medical Center

    Neptune City, New Jersey, 07753, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.